Company Filing History:
4 out of 202 
1 out of 1,245 
Years Active: 2009-2016
Title: Innovative Contributions of Inventor Sarah Wright
Introduction
Sarah Wright, a prominent inventor based in San Francisco, CA, has made significant advancements in the field of medical research. With a total of five patents to her name, her work primarily focuses on combating amyloidogenic diseases, particularly Alzheimer's.
Latest Patents
Two of her latest patents demonstrate groundbreaking methodologies for treating these complex conditions. The first patent, titled "Use of Perlecan Domain V in Treating Amyloidogenic Disease," reports that perlecan domain V (DV) or the LG3 domain significantly reduces the deposition and toxicity of the Aβ peptide, a crucial component in Alzheimer's plaques. The application elaborates on methods involving DV, LG3, and other related molecules in the treatment of amyloidogenic diseases.
The second patent, "Methods of Using DV, LG3 and Related Molecules in Treatment of Amyloidogenic Diseases," outlines techniques and compositions for inhibiting the toxicity of amyloidogenic proteins. It focuses on the inhibition of amyloidogenic protein deposit formation and provides treatment options by administering a pharmaceutically effective amount of agents that bind to integrins or integrin subunits.
Career Highlights
Throughout her career, Sarah has been associated with notable organizations such as Elan Pharmaceuticals and the Texas A&M University System. Her contributions here have furthered the understanding of amyloid-related diseases and paved the way for innovative treatments.
Collaborations
Sarah has worked alongside esteemed colleagues, including Irene Griswold-Prenner and Theodore A. Yednock. Their collaborations have enhanced the collective research efforts aimed at tackling challenging amyloidogenic conditions.
Conclusion
Sarah Wright's innovative spirit and dedication to her field continue to impact the lives of those affected by amyloidogenic diseases. Through her patents and collaborative work, she exemplifies the role of inventors in leading advancements in medical science.